White Matter Lesions Contribute to Motor and Non-motor Disorders in Parkinson's Disease: a Critical Review

Overview

Journal Geroscience

Specialty Geriatrics

Date 2024 Nov 22

PMID 39576561

Authors

Yue-Qi Jiang

Qiu-Zhu Chen

Yang Yang

Cai-Xia Zang

Jing-Wei Ma

Jin-Rong Wang

Yi-Rong Dong

Ning Zhou

Xing Yang

Fang-Fang Li

Xiu-Qi Bao

Dan Zhang

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a prevalent neurodegenerative disease, characterized by movement disorders and non-motor symptoms like cognitive impairment and depression. Degeneration of dopaminergic neurons in the substantia nigra and Lewy bodies have long been considered as main neuropathological changes. However, recent magnetic resonance imaging (MRI) studies have shown that white matter lesions (WMLs) were present in PD patients. WMLs are characterized by loss or impairment of myelin sheath in central nerve fibers, which are closely correlated with motor and cognitive dysfunction in PD. WMLs alterations precede nigrostriatal neuronal losses and can independently affect the clinical severity or characteristics of motor coordination in PD patients. Currently, the exact mechanism of WMLs involvement in the occurrence and development of PD remains unclear. It is speculated that WMLs may participate in the pathogenesis of PD by disrupting important connections in brain or promoting axonal degeneration. In this review, we will discuss the pathological changes and mechanisms of WMLs, elaborate the impact of WMLs on the progression of PD, clarify the importance of WMLs in PD pathogenesis, and thus provide novel targets for PD treatments.

References

Sampaio-Baptista C, Johansen-Berg H . White Matter Plasticity in the Adult Brain. Neuron. 2017; 96(6):1239-1251. PMC: 5766826. DOI: 10.1016/j.neuron.2017.11.026. View

Fang E, Fartaria M, Ann C, Marechal B, Kober T, Lim J . Clinical correlates of white matter lesions in Parkinson's disease using automated multi-modal segmentation measures. J Neurol Sci. 2021; 427:117518. DOI: 10.1016/j.jns.2021.117518. View

Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H . Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008; 70(12):935-42. DOI: 10.1212/01.wnl.0000305959.46197.e6. View

Ogama N, Endo H, Satake S, Niida S, Arai H, Sakurai T . Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment. J Cachexia Sarcopenia Muscle. 2021; 12(6):2045-2055. PMC: 8718089. DOI: 10.1002/jcsm.12807. View

Ye H, Robak L, Yu M, Cykowski M, Shulman J . Genetics and Pathogenesis of Parkinson's Syndrome. Annu Rev Pathol. 2022; 18:95-121. PMC: 10290758. DOI: 10.1146/annurev-pathmechdis-031521-034145. View

Raza C, Anjum R, Shakeel N . Parkinson's disease: Mechanisms, translational models and management strategies. Life Sci. 2019; 226:77-90. DOI: 10.1016/j.lfs.2019.03.057. View

Taylor K, Sambataro F, Boess F, Bertolino A, Dukart J . Progressive Decline in Gray and White Matter Integrity in Parkinson's Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data. Front Aging Neurosci. 2018; 10:318. PMC: 6186956. DOI: 10.3389/fnagi.2018.00318. View

de Schipper L, Hafkemeijer A, Bouts M, van der Grond J, Marinus J, Henselmans J . Age- and disease-related cerebral white matter changes in patients with Parkinson's disease. Neurobiol Aging. 2019; 80:203-209. DOI: 10.1016/j.neurobiolaging.2019.05.004. View

Kang P, Ying C, Chen Y, Ford A, An H, Lee J . Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease. Stroke. 2021; 53(5):1570-1579. PMC: 9038643. DOI: 10.1161/STROKEAHA.121.035674. View

10.

Lahna D, Schwartz D, Woltjer R, Black S, Roese N, Dodge H . Venous Collagenosis as Pathogenesis of White Matter Hyperintensity. Ann Neurol. 2022; 92(6):992-1000. PMC: 9671829. DOI: 10.1002/ana.26487. View

11.

He E, Liu M, Gong S, Fu X, Han Y, Deng F . White Matter Alterations in Depressive Disorder. Front Immunol. 2022; 13:826812. PMC: 9133348. DOI: 10.3389/fimmu.2022.826812. View

12.

Lin J, Wang D, Lan L, Fan Y . Multiple Factors Involved in the Pathogenesis of White Matter Lesions. Biomed Res Int. 2017; 2017:9372050. PMC: 5339523. DOI: 10.1155/2017/9372050. View

13.

Meng F, Yang Y, Jin G . Research Progress on MRI for White Matter Hyperintensity of Presumed Vascular Origin and Cognitive Impairment. Front Neurol. 2022; 13:865920. PMC: 9301233. DOI: 10.3389/fneur.2022.865920. View

14.

Wardlaw J, Smith C, Dichgans M . Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019; 18(7):684-696. DOI: 10.1016/S1474-4422(19)30079-1. View

15.

Starr J, Wardlaw J, Ferguson K, Maclullich A, Deary I, Marshall I . Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2002; 74(1):70-6. PMC: 1738177. DOI: 10.1136/jnnp.74.1.70. View

16.

Zhang C, Wong S, van de Haar H, Staals J, Jansen J, Jeukens C . Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology. 2016; 88(5):426-432. DOI: 10.1212/WNL.0000000000003556. View

17.

Denver P, DAdamo H, Hu S, Zuo X, Zhu C, Okuma C . A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease. Front Physiol. 2019; 10:1269. PMC: 6821690. DOI: 10.3389/fphys.2019.01269. View

18.

Farrall A, Wardlaw J . Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis. Neurobiol Aging. 2007; 30(3):337-52. DOI: 10.1016/j.neurobiolaging.2007.07.015. View

19.

Keith J, Gao F, Noor R, Kiss A, Balasubramaniam G, Au K . Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?. J Neuropathol Exp Neurol. 2017; 76(4):299-312. DOI: 10.1093/jnen/nlx009. View

20.

Rastogi A, Weissert R, Bhaskar S . Emerging role of white matter lesions in cerebrovascular disease. Eur J Neurosci. 2021; 54(4):5531-5559. DOI: 10.1111/ejn.15379. View